
Patients with a cystatin C-based estimated glomerular filtration rate more than 30% lower than their serum creatinine-based eGFR have a higher risk of adverse events with renally cleared cancer medications.


coremsg

Discordance between serum creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR) was associated with a higher risk of medication-related adverse events in patients with cancer.

A Risk for Adverse Events in Cancer Meds Cleared Renally

higher-risk-of-adverse-events-in-renally-cleared-cancer-medications


Higher Risk of Adverse Events in Renally Cleared Cancer Medications
